M

Magnet Biomedicine

Develops small-molecule molecular glue therapeutics

Scientist 1/2 - Biomolecular Discovery

Translational Research & Bench BiologyConfirmed live in the last 24 hours
Full-timeBoston, MA, USA$115k - $155kIn-person

About the Job

Requirements

  • A PhD or BS/MS in structural biology, biophysics, biochemistry, or a related field, with 0–5 years of industrial drug discovery experience for PhD holders or 4–10 years for BS/MS holders.
  • Hands-on laboratory experience in recombinant protein construct design, expression, and purification.
  • Ability to work independently and collaboratively to progress team objectives.

Responsibilities

  • Design plasmid constructs and optimize recombinant protein expression in bacterial (E. coli), insect, or mammalian cell systems.
  • Execute multi-step protein purification using affinity, ion-exchange, hydrophobic interaction, and size-exclusion chromatography.
  • Analyze protein purity, stability, and integrity using SDS-PAGE, Western blotting, UV/Vis spectroscopy, and fluorescence-based assays.
  • Assess compound perturbation of protein-protein interactions using techniques such as FP, TR-FRET, and luminescence.
  • Support X-ray crystallography data collection and analysis, and communicate structural insights with collaborators.
  • Maintain detailed electronic laboratory notebooks, calibrate equipment, and prepare comprehensive reports.

Desired Qualifications

  • Experience with structural biology methods such as X-ray crystallography, cryo-EM, native mass spectrometry, or HDxMS.
  • Experience in proximity-induced small molecule drug discovery.

About the Company

Magnet Biomedicine

Develops small-molecule molecular glue therapeutics

Magnet Biomedicine builds small-molecule therapeutics called molecular glues that modulate protein–protein interactions to address targets that are hard to drug. Its TrueGlue platform uses proprietary chemical libraries and human biology to select targets and design glues that recruit a presenter protein to a disease-relevant target, altering function or stability rather than simply degrading it. The company differentiates itself by aiming for tissue-specific effects and a broader range of outcomes beyond degradation, backed by chemistry-driven discovery and strong industry partnerships. Its goal is to bring novel medicines to patients, focusing on oncology, cardiovascular disease, and immune disorders, with collaborations like the Lilly deal to accelerate development and commercialization.

Company size
11-50
Company stage
Series A
Total funding
$50M
Headquarters
Boston, MA
Founded
2021

Recently Posted Jobs

Explore more opportunities at Magnet Biomedicine

See more jobs